Weekly Roundup: June 12, 2019


Jack Rawson

Episode Description

This week, the team discuss Vertex’s acquisition of Exonics and expansion of its collaboration with CRISPR Therapeutics. Also, we take an indepth look at the European Medicines Agency’s approval of Bluebirdbio’s gene therapy Zynteglo as a treatment for beta-thalassemia.

Presenter: Aparna Krishnan

Contributor: Jack Rawson

Producer: Aparna Krishnan

Latest episodes

Share this podcast